Complement Factor H Deficiency and Posttransplantation Glomerulonephritis With Isolated C3 Deposits

American Journal of Kidney Diseases

Volumn 51, Issue 4, 2008, Pages 671-677

  Boyer, Olivia ^a   Noël, Laure Hélène ^b   Balzamo, Eve ^a   Guest, Geneviève ^a   Biebuyck, Nathalie ^a   Charbit, Marina ^a   Salomon, Rémi ^a   Frémeaux Bacchi, Véronique ^c   Niaudet, Patrick ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b INSERM   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

C3; complement factor H (CFH); complement factor I (CFI); factor H; factor I; Hemolytic uremic syndrome (HUS); membrane cofactor protein (MCP); membranoproliferative glomerulonephritis (MPGN); pediatric; renal transplantation

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; COMPLEMENT FACTOR I; MEMBRANE COFACTOR PROTEIN;

ADOLESCENT; ALLOGRAFT; ARTICLE; BLOOD CELL COUNT; CASE REPORT; COMPLEMENT DEFICIENCY; COMPLEMENT FACTOR H DEFICIENCY; DNA POLYMORPHISM; GENE MUTATION; GLOMERULONEPHRITIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MALE; PRESCHOOL CHILD; THROMBOTIC THROMBOCYTOPENIC PURPURA;

CHILD, PRESCHOOL; COMPLEMENT C3; COMPLEMENT FACTOR H; GLOMERULONEPHRITIS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS;

EID: 40849147541     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2007.11.032     Document Type: Article

References (31)

1. Dragon-Durey M.A., and Fremeaux-Bacchi V. Atypical haemolytic uraemic syndrome and mutations in complement regulator genes. Springer Semin Immunopathol 27 (2005) 359-374
2. Dragon-Durey M.A., Fremeaux-Bacchi V., Loirat C., et al. Heterozygous and homozygous factor H deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: Report and genetic analysis of 16 cases. J Am Soc Nephrol 15 (2004) 787-795
3. Caprioli J., Noris M., Brioschi S., et al. Genetics of HUS: The impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 108 (2006) 1267-1279
4. Jokiranta T.S., Jaakola V.P., Lehtinen M.J., et al. Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome. EMBO J 25 (2006) 1784-1794
5. Saunders R.E., Abarrategui-Garrido C., Fremeaux-Bacchi V., et al. The interactive factor H-atypical hemolytic uremic syndrome mutation database and Website: Update and integration of membrane cofactor protein and factor I mutations with structural models. Hum Mutat 28 (2007) 222-234
6. Bresin E., Daina E., Noris M., et al. Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: Prognostic significance of genetic background. Clin J Am Soc Nephrol 1 (2006) 88-99
7. Goodship T.H. Factor H genotype-phenotype correlations: Lessons from aHUS, MPGN II, and AMD. Kidney Int 70 (2006) 12-13
8. Levy M., Halbwachs-Mecarelli L., Gubler M.C., et al. H deficiency in two brothers with atypical dense intramembranous deposit disease. Kidney Int 30 (1986) 949-956
9. Vogt B.A., Wyatt R.J., Burke B.A., et al. Inherited factor H deficiency and collagen type III glomerulopathy. Pediatr Nephrol 9 (1995) 11-15
10. Brai M., Misiano G., Maringhini S., et al. Combined homozygous factor H and heterozygous C2 deficiency in an Italian family. J Clin Immunol 8 (1988) 50-56
11. Servais A., Fremeaux-Bacchi V., Lequintrec M., et al. Primary glomerulonephritis with isolated C3 deposits: A new entity which shares common genetic risk factors with hemolytic uremic syndrome. J Med Genet 44 (2007) 193-199
12. Fremeaux-Bacchi V., Dragon-Durey M.A., Blouin J., et al. Complement factor I: A susceptibility gene for atypical haemolytic uraemic syndrome. J Med Genet 41 (2004) e84
13. Fremeaux-Bacchi V., Moulton E.A., Kavanagh D., et al. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. J Am Soc Nephrol 17 (2006) 2017-2025
14. Fakhouri F., Darre S., Droz D., et al. Mesangial IgG glomerulonephritis: A distinct type of primary glomerulonephritis. J Am Soc Nephrol 13 (2002) 379-387
15. Turner D.R., Cameron J.S., Bewick M., et al. Transplantation in mesangiocapillary glomerulonephritis with intramembranous dense "deposits": Recurrence of disease. Kidney Int 9 (1976) 439-448
16. Droz D., Nabarra B., Noel L.H., et al. Recurrence of dense deposits in transplanted kidneys: I. Sequential survey of the lesions. Kidney Int 15 (1979) 386-395
17. Beaufils H., Gubler M.C., Karam J., et al. Dense deposit disease: Long term follow-up of three cases of recurrence after transplantation. Clin Nephrol 7 (1977) 31-37
18. Andresdottir M.B., Assmann K.J., Hoitsma A.J., et al. Renal transplantation in patients with dense deposit disease: Morphological characteristics of recurrent disease and clinical outcome. Nephrol Dial Transplant 14 (1999) 1723-1731
19. Licht C., Heinen S., Jozsi M., et al. Deletion of Lys224 in regulatory domain 4 of factor H reveals a novel pathomechanism for dense deposit disease (MPGN II). Kidney Int 70 (2006) 42-50
20. Hamburger J., Hinglais N., and Noel L.H. [Classification of glomerulonephritides]. Ann Med Interne (Paris) 127 (1976) 133-137
21. Vaziri-Sani F., Holmberg L., Sjoholm A.G., et al. Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome. Kidney Int 69 (2006) 981-988
22. Ying L., Katz Y., Schlesinger M., et al. Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome. Am J Hum Genet 65 (1999) 1538-1546
23. Ault B.H. Factor H and the pathogenesis of renal diseases. Pediatr Nephrol 14 (2000) 1045-1053
24. Noris M., Brioschi S., Caprioli J., et al. Familial haemolytic uraemic syndrome and an MCP mutation. Lancet 362 (2003) 1542-1547
25. Hogasen K., Jansen J.H., Mollnes T.E., et al. Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency. J Clin Invest 95 (1995) 1054-1061
26. Pickering M.C., Cook H.T., Warren J., et al. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet 31 (2002) 424-428
27. Pickering M.C., Warren J., Rose K.L., et al. Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice. Proc Natl Acad Sci U S A 103 (2006) 9649-9654
28. Kavanagh D., Kemp E.J., Mayland E., et al. Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome. J Am Soc Nephrol 16 (2005) 2150-2155
29. Esparza-Gordillo J., Jorge E.G., Garrido C.A., et al. Insights into hemolytic uremic syndrome: Segregation of three independent predisposition factors in a large, multiple affected pedigree. Mol Immunol 43 (2006) 1769-1775
30. Genel F., Sjoholm A.G., Skattum L., et al. Complement factor I deficiency associated with recurrent infections, vasculitis and immune complex glomerulonephritis. Scand J Infect Dis 37 (2005) 615-618
31. Esparza-Gordillo J., Goicoechea de Jorge E., Buil A., et al. Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32. Hum Mol Genet 14 (2005) 703-712